Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully integrated, commercial biotechnology ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 29% to $2.36 during Monday’s session after the company effected a 1-for-32 reverse stock split of its common stock. The ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw its shares decline Thursday morning after the company filed a Form S-3 with the U.S. Securities and Exchange Commission. What To Know: The filing ...

The recent outbreak of the mpox virus has thrown companies like Tonix Pharmaceuticals (TNXP) into the limelight as it presses ahead with the preclinical development of its mpox vaccine candidate, ...

We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Tonix Pharmaceuticals Corp. (NASDAQ:TNXP) stands against other stocks ...

We recently published an article titled Micro-, Small-Cap Firms Dominate Market Rally. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands ...

Tonix Pharmaceuticals (NASDAQ:TNXP) added ~10% on Thursday after the company announced peer-reviewed data from a Phase 3 trial for its pain therapy candidate TNX-102 SL, and new findings related to ...

Amid an ongoing mpox outbreak, Tonix Pharmaceuticals (NASDAQ:TNXP) extended gains on Friday as part of a broader rally of rival vaccine developers after the company said its experimental mpox shot ...

Shares of Tonix Pharmaceuticals Holding Corp. (TNXP) traded 22% lower in Thursday’s pre-market session after the company announced share sale plans on Wednesday. The company entered into a sales ...

Tonix Pharmaceuticals (NASDAQ:TNXP) stock is falling on Thursday after the biopharmaceutical company announced a proposed public offering for its shares. Tonix Pharmaceuticals doesn’t have the finer ...